Get the QMS Strategies You Need to Attract Investors and Drive MedTech Wins

Get the actionable strategies you need to build or refine your Quality Management System (QMS), gain insights into how operational excellence influences investor interest and valuation, and uncover practical steps to position your startup for smoother scaling and stronger acquisition potential.

In today’s MedTech landscape, operational excellence isn’t just a best practice—it’s a non-negotiable. Startups that establish a robust QMS early on avoid costly pitfalls and secure a decisive competitive edge. With roughly 67% of Class 1 recalls linked to acquired products, the data is clear: a sound QMS matters.

Join us on January 29, 2025, at UCSF Mission Bay Rock Hall for an in-person-only event where industry experts—from investors and strategics to QMS consultants—will share why QMS readiness is pivotal for acquisition success, what drives valuation, and which practical tactics you can adopt right now to elevate your company’s operational foundation.

Panelists:

• Cynthia Yee (Investor Perspective) – Partner, Vensana Capital
• Nicolle Cannon (QMS Expert) – Founder, Cannon Quality Group
• Jeff Royal (Strategic Voice) – Director of Business Development, Johnson & Johnson

6:00 PM | Networking

Key Takeaways:

• Learn why early QMS adoption is critical to scaling and acquisition success.
• Gain insights into how operational excellence influences valuation and investor confidence.
• Understand practical, implementable steps to build or refine your QMS framework.

Optional Add-On:
3:30 – 4:30 PM | Q&A with QMS Expert Nicolle Cannon
Arrive early for a small-group session tailored to your specific QMS questions. This is a valuable opportunity for personalized insights, but completely optional—if you can only make it to the 5:00 PM session, you’ll still get the full spectrum of knowledge and strategic advice.

About the Speakers:

Cynthia Yee is a Partner at Vensana Capital. Cynthia brings nearly two decades of investing, operating, and public equities experience to Vensana. Prior to joining Vensana, she served as a Principal at Windham Venture Partners, where she led the firm’s investments in multiple companies, including Cartiva Medical (acquired), ClarVista Medical (acquired), Personal Genome Diagnostics (acquired) and NeuSpera Medical. She was previously an investor at NEA working across its medtech and healthcare services practices, and she spent time in business development and strategic marketing at Epix Therapeutics and medtech incubator D3DC. Cynthia began her career in public equities, covering medical devices at Piper Jaffray and biotechnology at Pacific Growth Equities. Cynthia currently serves on the board of directors of Evident Vascular and SpyGlass Pharma. She graduated from the University of California, Berkeley with a BA in Integrative Biology and a BS in Business Administration at the Haas School of Business.

Nicolle Cannon, Founder & CEO of Cannon Quality Group, is celebrating her 10th year of growing an engineer-minded Quality Assurance professional support organization. The team at CQG are focused on helping organizations take the fear out of quality and implementing smarter quality management systems that add value to the business.

Jeff Royal has over 25 years of experience in the medical devices industry focusing on corporate strategy, business development, licensing, mergers and acquisitions, program management and R&D.

Host or Publisher UCSF Rosenman Institute